Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide for Alcohol Use Disorder
NCT02900352Phase 3Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Oct 2016
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol use disorder (AUD) comparing Zonisamide with Placebo (2 arms). Primary endpoint: Number of Drinks Per Week at 16 weeks. Started Oct 2016; status: completed.
02
Drugs
zonisamide
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02900352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02900352.